NovaPure® Components For The Lifecycle Of Your Injectable Drug Product

By Julianna Clark


As drug products increase in complexity, become more specialized, and trend towards self-administration, it is more important than ever to have a reliable drug closure system.

Pharmaceutical manufacturers need components that can support all phases of drug development from discovery to commercialization with high quality level and pedigree and that can support both small batches and commercial manufacturing. West recognizes that sensitive and high-value drug products have a particular need for high-quality components with optimal performance and continuous innovation.

As companies move to commercialization, and scale up, they are able to leverage the knowledge gained on the closure during development. By reducing the loss of drug products caused by defects in primary packaging components, companies will be able to reduce quality investigations and treat more patients.

NovaPure® components are a critical feature of these systems and are designed to work with the other components of the primary packaging system to form an integral seal. In this article, learn more about the NovaPure® portfolio of components, an excellent option for managing product life cycle as it has the highest quality offerings of vial stoppers, pre-filled syringe (PFS) plungers, and cartridge components in a common elastomer formulation.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.

Subscribe to Biosimilar Development X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Biosimilar Development

West Pharmaceutical Services, Inc.